American Heart Journal
Volume 155, Issue 1 , Pages 19-25 , January 2008

Rationale and design of the Trial of Routine ANgioplasty and Stenting After Fibrinolysis to Enhance Reperfusion in Acute Myocardial Infarction (TRANSFER-AMI)

  • Warren J. Cantor, MD

      Affiliations

    • Southlake Regional Health Centre, Newmarket, Ontario, Canada
    • University of Toronto, Toronto, Ontario, Canada
    • Corresponding Author InformationReprint requests: Warren J. Cantor, MD, Southlake Regional Health Centre, 596 Davis Drive, Newmarket, Ontario, Canada L3Y 2P9.
    • ,
  • David Fitchett, MD

      Affiliations

    • University of Toronto, Toronto, Ontario, Canada
    • Terrence Donnelly Heart Centre, Division of Cardiology, St. Michael's Hospital, Toronto, Ontario, Canada
    • Canadian Heart Research Centre, Toronto, Ontario, Canada
    • ,
  • Bjug Borgundvaag, MD

      Affiliations

    • University of Toronto, Toronto, Ontario, Canada
    • Mount Sinai Hospital, Toronto, Ontario, Canada
    • ,
  • Michael Heffernan, MD

      Affiliations

    • Halton Healthcare Services, Oakville, Ontario, Canada
    • ,
  • Eric A. Cohen, MD

      Affiliations

    • University of Toronto, Toronto, Ontario, Canada
    • Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
    • ,
  • Laurie J. Morrison, MD

      Affiliations

    • University of Toronto, Toronto, Ontario, Canada
    • Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
    • ,
  • Anatoly Langer, MD

      Affiliations

    • University of Toronto, Toronto, Ontario, Canada
    • Terrence Donnelly Heart Centre, Division of Cardiology, St. Michael's Hospital, Toronto, Ontario, Canada
    • Canadian Heart Research Centre, Toronto, Ontario, Canada
    • ,
  • Shamir Mehta, MD

      Affiliations

    • McMaster University and Hamilton Health Sciences Corporation, Hamilton, Ontario, Canada
    • ,
  • Charles Lazzam, MD

      Affiliations

    • Trillium Health Centre, Mississauga, Ontario, Canada
    • ,
  • Brian Schwartz, MD

      Affiliations

    • University of Toronto, Toronto, Ontario, Canada
    • Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
    • ,
  • Vladimir Dzavik, MD

      Affiliations

    • University of Toronto, Toronto, Ontario, Canada
    • University Health Network, Toronto, Ontario, Canada
    • ,
  • Shaun G. Goodman, MD

      Affiliations

    • University of Toronto, Toronto, Ontario, Canada
    • Terrence Donnelly Heart Centre, Division of Cardiology, St. Michael's Hospital, Toronto, Ontario, Canada
    • Canadian Heart Research Centre, Toronto, Ontario, Canada

Received 1 June 2007 ,Accepted 27 August 2007.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 This study was supported by a grant from the Canadian Institutes of Health Research and an unrestricted grant from Hoffman La Roche, Canada.

 Dr Warren Cantor has received consulting fees, speaker's honoraria, and unrestricted research grants from Hoffman La Roche Canada and from Sanofi-Aventis.

 Dr Laurie Morrison has received speaker's honoraria from Hoffman La Roche and unrestricted research grants from Sanofi-Aventis.

 Dr Shaun Goodman has received consulting fees, speaker's honoraria, and research grants from Boehringer Ingelheim, Hoffmann La Roche, and Sanofi-Aventis.

 Dr Eric Cohen has received consulting fees and speaker's honoraria from Hoffman La Roche Canada and from Sanofi-Aventis.

 Dr David Fitchett has received consulting fees and speaker's honoraria from Hoffman La Roche, Bristol-Myers-Squibb, and Sanofi-Aventis.

 Dr David Fitchett has received consulting fees and speaker's honoraria from Hoffman La Roche, Bristol-Myers-Squibb, and Sanofi-Aventis

 Dr Bjug Borgundvaag has received consulting fees, speaker's honoraria and/or unrestricted research grants from Hoffman La Roche Canada, Sanofi-Aventis, and Key Pharmaceuticals.

 Dr Shamir Mehta has received consulting fees and/or speaker's honoraria and/or unrestricted research grants from Sanofi-Aventis, Bristol-Myers-Squibb, Astra Zeneca, Eli Lilly, Boston Scientific, GlaxoSmithKline, Oryx Pharmaceuticals, Abbott, Johnson and Johnson.

 Dr Michael Heffernan has received speaker's honoraria from Sanofi-Aventis.

 Dr Anatoly Langer has received consulting fees and/or speaker's honoraria and/or unrestricted research grants from Hoffman La Roche Canada, Astra Zeneca, Bayer, Biovail, BMS, Boston Scientific, Cordis (J&J), DuPont, Eli Lilly, Fournier, GlaxoSmithKline, Guidant, Medtronic, Merck Schering, Novartis, Oryx, Pfizer, Sanofi-Aventis, and Servier.

PII: S0002-8703(07)00711-9

doi: 10.1016/j.ahj.2007.08.025

American Heart Journal
Volume 155, Issue 1 , Pages 19-25 , January 2008

Article Tools

* Image Usage & Resolution